HealthQuill Longevity
AbbVie Inc., will buy Cerevel Therapeutics, developing drugs for neuroscience diseases, for $8.7 billion in a bid to boost the North Chicago, Illinois-based company’s presence in the psychiatric and neurological disorder segment.
Climate Health Medical

Human life expectancy has hit its upper limits, says US research

HQ Team October 8, 2024:Humanity is hitting the upper limit of life expectancy, according to a new study. Medical advances have led to.

Read More
Japan’s radiologists using chest radiographs developed an AI model to accurately predict a human’s chronological age and detect chronic diseases.
Drugs Health Pharma

Japan’s radiologists invent AI model to predict age from chest graphs 

HQ Team August 18, 2023: Japan’s radiologists using chest radiographs developed an AI model to accurately predict a human’s chronological age and detect.

Read More